Showing results (131-140 of 588) with videos related to
Sort By:
Pageof 59
Anti-Cancer Drugs|April 5, 2013
Chemotherapy in metastatic renal cell carcinoma today? A systematic reviewSebastiano Buti, Melissa Bersanelli, Angelica Sikokis, et al.Clinical Genitourinary Cancer|July 3, 2013
Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agentsFrancesco Massari, Emilio Bria, Francesca Maines, et al.European Radiology|March 29, 2003
Contrast-enhanced computed tomographic colonography in the follow-up of colorectal cancer patients: a feasibility studyAndrea Laghi, Riccardo Iannaccone, Emilio Bria, et al.Journal of Experimental & Clinical Cancer Research : CR|December 31, 2011
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical researchMaria Bonomi, Sara Pilotto, Michele Milella, et al.Translational Lung Cancer Research|January 23, 2016
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancerSara Pilotto, Luisa Carbognin, Niki Karachaliou, et al.The Oncologist|February 12, 2016
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant SettingLuisa Carbognin, Sara Pilotto, Rolando Nortilli, et al.Current Problems in Cancer|September 7, 2021
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLCSabrina Rossi, Paola Damiano, Luca Toschi, et al.Eclinicalmedicine|January 30, 2023
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysisLuca Mastrantoni, Armando Orlandi, Antonella Palazzo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1Sergio Pecorelli, Giuseppe Favalli, Angiolo Gadducci, et al.Cancer|January 8, 2005
Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinomaEmilio Bria, Diana Giannarelli, Alessandra Felici, et al.Pageof 59